Revealing True Functional Biology to Accelerate Research and Medicine
Our Single Cell Proteomics have uncovered a range of unique biological insights that are illuminating the underlying drivers complex disease. We provide an automated suite of life sciences products and are powering the future of advanced medicines to fight these diseases.
Proteomic Products:
Our single-cell proteomics and ultra small volume omic products (omics = highly multiplexed) are revealing a direct view into functional biology, to power researchers’ most important work
New Product Updates and Customer Stories
Stay at the cutting edge of science and medicine with our new products, publications, and customer stories
Harnessing the power of functional proteomics with the IsoLight™.
New Publications View All
- Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line
- CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
- Advanced Cell Mapping Visualizations for Single Cell Functional Proteomics Enabling Patient Stratification
Latest Customer Stories View All
- Polyfunctionality in T Cells Correlates Vaccine-Induced Durable Protective Immunity, Revealed with Single-Cell Proteomics
- IsoPlexis’ Single-Cell Proteomics Tackles Vaccine Development: Roundtable Discussion from Leading Infectious Disease Researchers
- A Multi-Omic Tour: Three Nature Publications on How Cells Communicate Via IsoPlexis' Proteomics
Single Cell Proteomics: Revolutionary Omic Solution
Our functional phenotyping provides a direct view into each single cell’s highly multiplexed secretome or intracellular proteome
Single cell differences typically defined by surface phenotype or genotype- IsoPlexis unique omics: Cell differences by extracellular or intracellular functional phenotype
- Impact: Customers Publishing ability to predict response and accelerate medicines using improved understanding of a variety of cell types
1
1
Functional PhenotypeSC Secretome
2
Functional PhenotypeSC Intracellular Proteome
3
Surface PhenotypeFlow Cytometry
4
Transcriptomic DefinitionRNA Seq
Publications Highlight Customer Breakthroughs across Immune Medicine
Review Case Studies Across Immune Medicine
See 70+ Publications
The IsoLight and IsoSpeak
The Hub for your Many Proteomic Applications
The Hub for your Many Proteomic Applications
Multiple Chip Products:
Many Applications
Single Cell Polyfunctional Strength 
Single Cell Polyfunctional Inflammation 
Single Cell Innate & Myeloid 
Single Cell Intracellular Proteome The IsoLight
Meet your lab’s daily proteomic needs through automation & software that provides ease of use
IsoSpeak Software
Automatically translate biomarkers and utilize intuitive visualizations to understand correlations in vivo
Traditional Workflow
Multiple Instruments Needed
Multiple Manual Workflow Steps
Automate Your Entire Workflow With One System
The IsoLight
See how our Systems are powering immune medicine via IsoSpeak
Join our global user community,
invent the future of medicine
“Quality assays are mainly descriptive with some objective parameters like cytokine production, cytotoxicity, and proliferation. Only recently, with PSI… can we start to differentiate products.”
Moffitt Cancer Center
“As a cancer research center with a key focus on CAR-T and other cell therapies, we feel that IsoPlexis will enable us to better characterize response and potentially predict whether cancer patients will respond to CAR-T therapy before treatment.”
City of Hope
“Current assays that rely on a single-plex ELISA or even multiparametric flow cytometry don’t give you the level of resolution that the IsoPlexis platform can provide.”
Director of Translational Sciences at Kite
“The ability of the IsoLight to provide detailed analyses from very few cells is key, given that we are limited to small sample quantities of blood.”
Associate Professor of Immunology at Karolinska Institute
“MD Anderson, IsoPlexis Link T-Cell Functionality to Immunotherapy Response in AML.”
“We see potential in utilizing IsoPlexis’ single-cell system to help provide deeper resolution into the functional impacts of our therapeutics… This collaboration will enable us to apply the sensitivity of this solution to further our understanding of patient-specific responses to our immune therapies.”
Chief Scientific Officer, Nektar Therapeutics
“The ability to easily perform single-cell proteomics provides a way to understand the complexity of the cellular response to immunotherapy and then to design and test new therapies to enhance efficacy.”
Director, Center for Synthetic Immunity, Professor, Geisel School of Medicine, Dartmouth College
“Through this research, we were able to highlight the important role a functionally versatile subpopulation of CAR-T cells may play in the fight against cancer. This could lead to new methods to optimize T-cell products.”
Vice President, Translation Sciences, Kite
“The best way to predict the
future is to invent it.”
